GT Biopharma, Inc.GTBPNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank79
3Y CAGR-25.0%
5Y CAGR+105.9%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
-25.0%/yr
Annual compound
5Y CAGR
+105.9%/yr
Recent deceleration
Percentile
P79
Within normal range
vs 5Y Ago
37x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $123000.00 | -69.4% |
| 2024 | $402000.00 | -48.5% |
| 2023 | $780000.00 | +167.1% |
| 2022 | $292000.00 | +668.4% |
| 2021 | $38000.00 | +1044.6% |
| 2020 | $3320.00 | +56.0% |
| 2019 | $2128.00 | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |